Action Items:
-
See new Data Quality Resolution process and guidance documents on the Data Toolkit page of myRADx-UPhome
- Nominate members of your team to attend the Equity Evidence Academy on Nov. 17 & 18 (qualifies for 2.5 credit hours of CMEs or CEUs)
|
|
Dear RADx-UP Partners,
A deep bow of gratitude to the eleven project teams that reviewed their preliminary data and lessons learned at the inaugural RADx-UP Scientific Meeting last Thursday. We learned from your insights and appreciated the acknowledgments of how important your community partners are to your RADx-UP interventions.
NIH Director Francis Collins joined us at the beginning to provide an overview of the RADx initiative and the related Say Yes! COVID Test program that is distributing at-home testing kits to a growing list of communities.
“If we don't emphasize in a very intentional way getting tests to the people who have been hardest hit by COVID-19, those underserved populations, then we're not doing our job. We're not living up to the demands that we now feel very strongly have to be part of NIH’s portfolio, which is addressing health inequities,” said Dr. Collins. “And so that's what RADx-UP is doing, and you are helping us with that in a way that we hope to learn so many things that ultimately in the course of history, this might be a significant turning point for how we approach health disparities.”
Eliseo Pérez-Stable, director of the National Institute on Minority Health and Health Disparities and co-chair of the RADx-UP Governance Committee, listened to each of the presentations and wrapped up the meeting with a nod to the impact of the work of the RADx-UP consortium.
|
|
If you attended the event, please provide your feedback so we can improve our preparations for the next RADx-UP Scientific Meeting.
Our CDCC team is working on a post-meeting report and preparation of the videos for sharing. For now, please join us in thanking the following presenters:
- May Okihiro & Ruben Juarez, University of Hawaii at Manoa
- Richard Yanagihara, University of Hawaii at Manoa
- John Schneider, The University of Chicago
- Tim VanWagoner, University of Oklahoma Health Sciences Center
- Rebekka Lee, Harvard T.H. Chan School of Public Health
- Sara Al-Dahir, Brittany Singleton, Christopher Gillard & Martha Earls, Xavier University of Louisiana
- Broderick Crawford & Vickie Collie-Allers, University of Kansas Medical Center
- Matthew Kreuter & Niko Verdecias, Washington University
- Lauren Brinkley-Rubinstein & Morgan Maner, Yale University & UNC Chapel Hill
- Kathleen Page, Alejandra Flores-Miller, Katherine Phillips, Ana Cervantes, Suzanne Grieb, Johns Hopkins University
- Janice Tsoh & Joyce Cheng, University of California, San Francisco
Stay tuned for information about how to collaborate on publication opportunities and when the next RADx-UP Scientific Meeting will take place.
|
|
Data Quality Resolution Process |
|
As of today, 48 RADx-UP projects are transferring data sets to the CDCC. Your experience is helping us improve the submission process to make it as straight-forward and consistent as possible. Please see new process and guidance documents on the Data Toolkit page of myRADx-UPhome:
-
Data Quality Resolution Process—This outlines the steps the CDCC will take to reconcile data transfers that don’t meet Data Submission Guidance standards.
-
Data Submission Guidance—This provides a high-level overview of the data submission process, the tools you’ll need, and the terminology used. This guide also includes examples of how to handle common issues that might come up.
-
Data Submission Tutorial—Video/podcast in which CDCC Data Core informaticists James and Bhargav walk through key issues around data submission and data conformance.
If you have questions about these documents or the data submission process, please contact your EIT. CDCC informaticists are available to consult with data managers on specific challenges that might come up.
|
|
Help RADx-UP Reach Every Corner of the U.S. |
The Community Collaboration Mini-Grant Program is currently accepting applications for the next cycle of awards. Deadline for this cycle is Dec. 10, 2021. The CDCC is seeking applications from states in which RADx-UP currently has little or no coverage. Please share this opportunity with your networks and contacts.
Both the Community Collaboration Mini-Grant Program (C2G) and the Rapid Research Pilot Program (RP2) have webinars scheduled in November to learn more about the opportunities and talk with CDCC mini-grant program staff. Register today.
|
|
CME credit for COVID-19 Equity Evidence Academy |
Note that the CDCC is able to provide continuing education credit to physicians (CMEs) nurses, and social workers (CEUs) for your attendance at the COVID-19 Equity Evidence Academy on Nov. 17 and 18. Attendees can earn up to 2.25 credit hours by participating in both of the breakout sessions on Nov. 17 and completing the session evaluation. This activity is jointly provided by RADx-UP and UNC Health Science at MAHEC's Department of Continuing Professional Development.
If you haven't nominated members of your team to attend this November's event, please do that now.
|
|
|
ReSET (Restarting Safe Education and Testing for Children with Medical Complexity) |
|
In a new video profile of the RADx-UP project in Wisconsin, Ryan Coller explains how the team is promoting safe return to school children with medical complexity.
“We’re exploring the feasibility of different testing strategies for children with medical complexity, including in-home and school-based testing, and the extent to which testing helps families feel more comfortable sending their child to school and helps children return to school quickly if they do develop symptoms.
|
|
In addition, knowing the child's COVID status more regularly and reliably can help schools feel comfortable and build in supports for the child and for the family. Every school is essentially reinventing the wheel and trying to figure out how to do this safely for their communities and for their children and families.”
|
|
Clinical Trial seeks participants for rapid at-home tests
Please help the Clinical Studies Core of RADx Tech spread the word about COVID-19 Test US with organizations and groups working with communities experiencing a high rate of COVID-19 cases in mainland US. COVID-19 Test Us is a new study providing rapid at-home tests at participants’ doorsteps. Study participants must be symptom-free and have a smartphone that they can use to enroll in the study. Participants will receive up to $250 as incentive for completing this three week study to understand how rapid COVID-19 tests can be used at home without a prescription.
|
|
English, Spanish materials available on ACTIV-6 website
There are no approved prescription medications that can be easily given at home to treat mild-to-moderate symptoms of COVID-19 early in its course to prevent worsening of COVID-19 symptoms and hospitalization. The NIH-funded ACTIV-6 study seeks to identify whether repurposed medications, already approved for other conditions by the Food and Drug Administration, are effective for treating COVID-19. People 30 and over who have COVID-19 symptoms and a positive test are eligible for the study. More information in English and Spanish is available on the expanded ACTIV-6 website resources page, or you may contact the Call Center at 833-385-1880.
|
|
 |
Giselle Corbie is an editor of a new book that collects insights from healthcare experts from nurses to social workers and presents a strategy to shift away from our fragmented and often judgmental approach to health. Leading Community Based Changes in the Culture of Health in the US - Experiences in Developing the Team and Impacting the Community is available for order here.
|
|
|
|
The Partnership for Public Service awarded NIMHD Director Dr. Eliseo J. Pérez-Stable the COVID-19 Response Medal in recognition of his leadership of two major federal programs—RADx-UP and the Community Engagement Alliance (CEAL) Against COVID-19 Disparities. Congratulations!
|
|
|
|
Use this form to alert the CDCC to resources like the item above or other information coming out of your project or community.
|
|
|
|
|
|
|
|
